Dopamine Released from TiO(2) Semicrystalline Lattice Implants Attenuates Motor Symptoms in Rats Treated with 6-Hydroxydopamine

[Image: see text] The motor dysfunction featured by patients aggrieved by Parkinson’s disease (PD) results from the reduction of dopamine (DA) availability in the caudate nucleus (CN). Restituting CN DA levels is therefore essential to ameliorate PD motor deficits. In this regard, nanotechnology may...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Chavarín, Margarita, Prado-Prone, Gina, Padilla, Patricia, Ramírez Santos, Jesús, Gutiérrez-Ospina, Gabriel, García-Macedo, Jorge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648478/
https://www.ncbi.nlm.nih.gov/pubmed/31459884
http://dx.doi.org/10.1021/acsomega.8b00626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648478/
https://www.ncbi.nlm.nih.gov/pubmed/31459884
http://dx.doi.org/10.1021/acsomega.8b00626

Ejemplares similares